Published in
Taylor and Francis Group, Journal of Asthma, 1(59), p. 189-199, 2020
DOI: 10.1080/02770903.2020.1837158
Links
Tools
Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in Singapore
Journal article published in 2020 by
Ling Eng Tan 
,
Wan Hui Gloria Tan ,
Mohamed Ismail Abdul Aziz ,
Mariko Siyue Koh ,
Tunn Ren Tay ,
Fiona Pearce,
Kwong Ng
,
Wan Hui Gloria Tan ,
Mohamed Ismail Abdul Aziz ,
Mariko Siyue Koh ,
Tunn Ren Tay ,
Fiona Pearce,
Kwong Ng
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 